Intravitreally Injected Methylene Blue Protects Retina against Acute Ocular Hypertension in Rats

References

• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901–11.
   PubMed Web of Science ®Google Scholar
• Pardue MT, Allen RS. Neuroprotective strategies for retinal disease. Prog Retin Eye Res. 2018;65:50–76.
   PubMed Web of Science ®Google Scholar
• Boland MV, Ervin AM, Friedman DS, Jampel HD, Hawkins BS, Vollenweider D, Chelladurai Y, Ward D, Suarez-Cuervo C, Robinson KA. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the u.S. Preventive services task force. Ann Intern Med. 2013;158:271–79.
   PubMed Web of Science ®Google Scholar
• Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, et al. Latanoprost for open-angle glaucoma (ukgts): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385(9975):1295–304.
   PubMed Web of Science ®Google Scholar
• Cherecheanu AP, Garhofer G, Schmidl D, Werkmeister R, Schmetterer L. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol. 2013;13:36–42.
   PubMed Web of Science ®Google Scholar
• Liu H, Anders F, Thanos S, Mann C, Liu A, Grus FH, Pfeiffer N, Prokosch-Willing V. Hydrogen sulfide protects retinal ganglion cells against glaucomatous injury in vitro and in vivo. Invest Ophthalmol Vis Sci. 2017;58:5129–41.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang L, Weinreb RN. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov. 2012;11:541–59.
   PubMed Web of Science ®Google Scholar
• Cheung W, Guo L, Cordeiro MF. Neuroprotection in glaucoma: drug-based approaches. Optom Vis Sci. 2008;85:406–16.
   PubMed Web of Science ®Google Scholar
• Mi XS, Feng Q, Lo AC, Chang RC, Lin B, Chung SK, So KF. Protection of retinal ganglion cells and retinal vasculature by lycium barbarum polysaccharides in a mouse model of acute ocular hypertension. PLoS One. 2012;7:e45469.
   PubMed Web of Science ®Google Scholar
• Huang Y, Cen LP, Luo JM, Wang N, Zhang MZ, van Rooijen N, Pang CP, Cui Q. Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension. Neuroscience. 2008;153:214–25.
   PubMed Web of Science ®Google Scholar
• Huang Y, Cen LP, Choy KW, van Rooijen N, Wang N, Pang CP, Cui Q. Jak/stat pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions. Exp Eye Res. 2007;85:684–95.
   PubMed Web of Science ®Google Scholar
• Johnson TV, Tomarev SI. Rodent models of glaucoma. Brain Res Bull. 2010;81:349–58.
   PubMed Web of Science ®Google Scholar
• Schirmer RH, Adler H, Pickhardt M, Mandelkow E. “Lest we forget you--methylene blue … ”. Neurobiol Aging. 2011;32:2325 e2327–2316.
   Web of Science ®Google Scholar
• Tucker D, Lu Y, Zhang Q. From mitochondrial function to neuroprotection-an emerging role for methylene blue. Mol Neurobiol. 2018;55:5137–53.
   PubMed Web of Science ®Google Scholar
• Chen ZW, Liu A, Liu Q, Chen J, Li WM, Chao XJ, Yang Q, Liu PQ, Mao ZX, Pi RB. Mef2d mediates the neuroprotective effect of methylene blue against glutamate-induced oxidative damage in ht22 hippocampal cells. Mol Neurobiol. 2017;54:2209–22.
   PubMed Web of Science ®Google Scholar
• Pakavathkumar P, Sharma G, Kaushal V, Foveau B, LeBlanc AC. Methylene blue inhibits caspases by oxidation of the catalytic cysteine. Sci Rep. 2015;5:13730.
   PubMed Web of Science ®Google Scholar
• Fenn AM, Skendelas JP, Moussa DN, Muccigrosso MM, Popovich PG, Lifshitz J, Eiferman DS, Godbout JP. Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice. J Neurotrauma. 2015;32:127–38.
   PubMed Web of Science ®Google Scholar
• Zhao M, Liang F, Xu H, Yan W, Zhang J. Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation. Mol Med Rep. 2016;13:13–20.
   PubMed Web of Science ®Google Scholar
• Atamna H, Nguyen A, Schultz C, Boyle K, Newberry J, Kato H, Ames BN. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J. 2008;22:703–12.
   PubMed Web of Science ®Google Scholar
• Zakaria A, Hamdi N, Abdel-Kader RM. Methylene blue improves brain mitochondrial abad functions and decreases abeta in a neuroinflammatory alzheimer’s disease mouse model. Mol Neurobiol. 2016;53:1220–28.
   PubMed Web of Science ®Google Scholar
• Yang SH, Li W, Sumien N, Forster M, Simpkins JW, Liu R. Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: methylene blue connects the dots. Prog Neurobiol. 2017;157:273–91.
   PubMed Web of Science ®Google Scholar
• Lu Q, Tucker D, Dong Y, Zhao N, Zhang Q. Neuroprotective and functional improvement effects of methylene blue in global cerebral ischemia. Mol Neurobiol. 2016;53:5344–55.
   PubMed Web of Science ®Google Scholar
• Rey-Funes M, Larrayoz IM, Fernandez JC, Contartese DS, Rolon F, Inserra PI, Martinez-Murillo R, Lopez-Costa JJ, Dorfman VB, Martinez A, et al. Methylene blue prevents retinal damage in an experimental model of ischemic proliferative retinopathy. Am J Physiol Regul Integr Comp Physiol. 2016;310(11):R1011–1019.
   PubMed Web of Science ®Google Scholar
• Rojas JC, John JM, Lee J, Gonzalez-Lima F. Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy. Neurotox Res. 2009;15:260–73.
   PubMed Web of Science ®Google Scholar
• Zhang X, Rojas JC, Gonzalez-Lima F. Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotox Res. 2006;9:47–57.
   PubMed Web of Science ®Google Scholar
• Hao J, Zhang H, Yu J, Chen X, Yang L. Methylene blue attenuates diabetic retinopathy by inhibiting nlrp3 inflammasome activation in stz-induced diabetic rats. Ocul Immunol Inflamm. 2019;27:836–43.
   PubMed Web of Science ®Google Scholar
• Mekala NK, Kurdys J, Depuydt MM, Vazquez EJ, Rosca MG. Apoptosis inducing factor deficiency causes retinal photoreceptor degeneration. The protective role of the redox compound methylene blue. Redox Biol. 2019;20:107–17.
   PubMed Web of Science ®Google Scholar
• Ko ML, Chen CF, Peng PH, Peng YH. Simvastatin upregulates bcl-2 expression and protects retinal neurons from early ischemia/reperfusion injury in the rat retina. Exp Eye Res. 2011;93:580–85.
   PubMed Web of Science ®Google Scholar
• Dreixler JC, Poston JN, Shaikh AR, Alexander M, Tupper KY, Marcet MM, Bernaudin M, Roth S. Delayed post-ischemic conditioning significantly improves the outcome after retinal ischemia. Exp Eye Res. 2011;92:521–27.
   PubMed Web of Science ®Google Scholar
• Mathew B, Poston JN, Dreixler JC, Torres L, Lopez J, Zelkha R, Balyasnikova I, Lesniak MS, Roth S. Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats. Graefes Arch Clin Exp Ophthalmol. 2017;255:1581–92.
   PubMed Web of Science ®Google Scholar
• Herman JP, Watson SJ. The rat brain in stereotaxic coordinates. 2nd ed. 1986. London: Academic Press.
   Google Scholar
• Chauhan BC, LeVatte TL, Jollimore CA, Yu PK, Reitsamer HA, Kelly ME, Yu DY, Tremblay F, Archibald ML. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144–52.
   PubMed Web of Science ®Google Scholar
• Varga B, Priksz D, Lampe N, Bombicz M, Kurucz A, Szabo AM, Posa A, Szabo R, Kemeny-Beke A, Remenyik J, et al. Protective effect of prunus cerasus (sour cherry) seed extract on the recovery of ischemia/reperfusion-induced retinal damage in Zucker diabetic fatty rat. Molecules. 2017;22(10):1782–94.
   Web of Science ®Google Scholar
• Zhou L, Chen W, Lin D, Hu W, Tang Z. Neuronal apoptosis, axon damage and synapse loss occur synchronously in acute ocular hypertension. Exp Eye Res. 2019;180:77–85.
   PubMed Web of Science ®Google Scholar
• Xiao-Yan Z, Yi-Qin X, Yu Z, Wen Y. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats. Invest Ophthalmol Vis Sci. 2013;54:3912.
   PubMed Web of Science ®Google Scholar
• Grozdanic SD, Sakaguchi DS, Kwon YH, Kardon RH, Sonea IM. Functional characterization of retina and optic nerve after acute ocular ischemia in rats. Invest Ophthalmol Vis Sci. 2003;44:2597–605.
   PubMed Web of Science ®Google Scholar
• Tan O, Chopra V, Lu AT, Schuman JS, Ishikawa H, Wollstein G, Varma R, Huang D. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology. 2009;116:2305–2314 e2301-2302.
   Web of Science ®Google Scholar
• Jehle T, Wingert K, Dimitriu C, Meschede W, Lasseck J, Bach M, Lagreze WA. Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest Ophthalmol Vis Sci. 2008;49:1056–64.
   PubMed Web of Science ®Google Scholar
• Chrysostomou V, Rezania F, Trounce IA, Crowston JG. Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol. 2013;13:12–15.
   PubMed Web of Science ®Google Scholar
• Siegfried CJ, Shui YB. Intraocular oxygen and antioxidant status: new insights on the effect of vitrectomy and glaucoma pathogenesis. Am J Ophthalmol. 2019;203:12–25.
   PubMedGoogle Scholar
• Dogan S, Unal M, Ozturk N, Yargicoglu P, Cort A, Spasojevic I, Batinic-Haberle I, Aslan M. Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats. Exp Eye Res. 2011;93:387–96.
   PubMed Web of Science ®Google Scholar
• Cort A, Ozturk N, Akpinar D, Unal M, Yucel G, Ciftcioglu A, Yargicoglu P, Aslan M. Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul Toxicol Pharmacol. 2010;58:121–30.
   PubMed Web of Science ®Google Scholar
• Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V, Smithies O, John SW. Vitamin b3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355:756–60.
   PubMed Web of Science ®Google Scholar
• Daudt DR 3rd, Mueller B, Park YH, Wen Y, Yorio T. Methylene blue protects primary rat retinal ganglion cells from cellular senescence. Invest Ophthalmol Vis Sci. 2012;53:4657–67.
   PubMed Web of Science ®Google Scholar
• Deliyanti D, Alrashdi SF, Tan SM, Meyer C, Ward KW, de Haan JB, Wilkinson-Berka JL. Nrf2 activation is a potential therapeutic approach to attenuate diabetic retinopathy. Invest Ophthalmol Vis Sci. 2018;59:815–25.
   PubMed Web of Science ®Google Scholar
• Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 2006;8:99–106.
   PubMed Web of Science ®Google Scholar
• Di Marco E, Jha JC, Sharma A, Wilkinson-Berka JL, Jandeleit-Dahm KA, de Haan JB. Are reactive oxygen species still the basis for diabetic complications? Clin Sci (Lond). 2015;129:199–216.
   PubMed Web of Science ®Google Scholar
• Cheng X, Siow RC, Mann GE. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-e2-related factor 2-kelch-like ech-associated protein 1 defense pathway. Antioxid Redox Signal. 2011;14:469–87.
   PubMed Web of Science ®Google Scholar
• Stack C, Jainuddin S, Elipenahli C, Gerges M, Starkova N, Starkov AA, Jove M, Portero-Otin M, Launay N, Pujol A, et al. Methylene blue upregulates nrf2/are genes and prevents tau-related neurotoxicity. Hum Mol Genet. 2014;23(14):3716–32.
   PubMed Web of Science ®Google Scholar
• El Sayed NS, Sayed AS. Protective effect of methylene blue on tnbs-induced colitis in rats mediated through the modulation of inflammatory and apoptotic signalling pathways. Arch Toxicol. 2019;93:2927–42.
   PubMed Web of Science ®Google Scholar
• Mancino R, Martucci A, Cesareo M, Giannini C, Corasaniti MT, Bagetta G, Nucci C. Glaucoma and Alzheimer disease: one age-related neurodegenerative disease of the brain. Curr Neuropharmacol. 2018;16:971–77.
   PubMed Web of Science ®Google Scholar
• Nucci C, Martucci A, Cesareo M, Garaci F, Morrone LA, Russo R, Corasaniti MT, Bagetta G, Mancino R. Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system. Prog Brain Res. 2015;221:49–65.
   PubMed Web of Science ®Google Scholar
• Gobel K, Erb C. [neurological disorders and glaucoma - an overview]. Klin Monbl Augenheilkd. 2014;231:130–35.
   PubMed Web of Science ®Google Scholar
• Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A. 2007;104(33):13444–49.
   PubMed Web of Science ®Google Scholar
• Wischik CM, Staff RT, Wischik DJ, Bentham P, Murray AD, Storey JM, Kook KA, Harrington CR. Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate alzheimer’s disease. J Alzheimers Dis. 2015;44:705–20.
   PubMed Web of Science ®Google Scholar
• Wilcock GK, Gauthier S, Frisoni GB, Jia J, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Schelter BO, Wischik DJ, et al. Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (lmtm) monotherapy for treatment of mild alzheimer’s disease: cohort analysis as modified primary outcome in a phase iii clinical trial. J Alzheimers Dis. 2018;61(1):435–57.
   PubMed Web of Science ®Google Scholar
• Mori T, Koyama N, Segawa T, Maeda M, Maruyama N, Kinoshita N, Hou H, Tan J, Town T. Methylene blue modulates beta-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice. J Biol Chem. 2014;289:30303–17.
   PubMed Web of Science ®Google Scholar
• Necula M, Breydo L, Milton S, Kayed R, van der Veer WE, Tone P, Glabe CG. Methylene blue inhibits amyloid abeta oligomerization by promoting fibrillization. Biochemistry. 2007;46:8850–60.
   PubMed Web of Science ®Google Scholar
• Medina DX, Caccamo A, Oddo S. Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol. 2011;21:140–49.
   PubMed Web of Science ®Google Scholar